Q3 2019 HTG Molecular Diagnostics Inc Earnings Call Transcript
Greetings, and welcome to the HTG Molecular Diagnostics Inc. Third Quarter 2019 Earnings Call. (Operator Instructions) Please note that this conference is being recorded.
I will now turn the conference over to your host, Monique Kosse, LifeSci Advisors. Please go ahead, ma'am.
Thank you, Jerry. Earlier today, HTG released its financial results for the quarter ended September 30, 2019.
Before we begin the call, let me remind you that the company's remarks include forward-looking statements within the meaning of federal security laws, including statements regarding possible additional collaborations with pharma customers; anticipated continued growth in RUO profiling business and related revenue; expected growth in and benefit from pharma programs and collaborations; product development and commercialization activities; revenue expectations for the full year 2019; and projects expected to occur in 2020.
These forward-looking statements are subject to numerous risks and uncertainties, many of
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |